<DOC>
	<DOCNO>NCT00555009</DOCNO>
	<brief_summary>To establish effect genotropin replacement cognitive function patient severe growth hormone deficiency traumatic brain injury .</brief_summary>
	<brief_title>Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury</brief_title>
	<detailed_description>The study terminate 15-Dec-2008 due inability recruit protocol specify patient population . The study terminate due safety concern .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Have previous traumatic brain injury ( 1 year less 20 year ) prior screen visit . Have Extended Glasgow Outcome Scale ( GOSE ) equal 5 . Have prove GHD deficiency Active systemic malignancy active intracranial tumor . A successfully treated tumor malignancy exclusion criterion patient active disease 5 year currently receive maintenance chemotherapy , ( except basal cell skin cancer . Receiving treatment prednisolone dose 10 mg/day treatment oral glucocorticosteroids replacement dose permit throughout study . Topical inhale corticosteroid permit . History dementia unrelated TBI History benign intracranial hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>traumatic brain Injury , cognitive function</keyword>
</DOC>